1-2 of 2
B. Labar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Incidence and Clinical Impact of TET2 Mutations in Acute Myeloid Leukemia Patients Treated within the EORTC/GIMEMA AML-12/06991 AML Trial.

M. G Aslanyan, S. M.C. Langemeijer, D. Cilloni, G. Saglio, JP Marie, R. Tang, B. Labar, R. Zadro, D. Batinic, S. Amadori, F. Lo Coco, T. Scheele, L. Kroeze, M. Massop, P. van Hoogen, E. Stevens, P. Muus, S. Suciu, L. Baila, E. W.A. Marijt, R. Willemze, T. de Witte, B. van der Reijden, J. H. Jansen
Journal: Blood
Blood (2009) 114 (22): 2609.
https://doi.org/10.1182/blood.V114.22.2609.2609
Published: 2009
Journal Articles

A New Prognostic Disease Specific Model To Predict Survival after Intensive Antileukemic Treatment for Young Patients with Poor-Risk MDS and AML: Results of the CRIANT and AML-10 Studies Conducted by the EORTC/GIMEMA/SAKK/HOVON/EBMT Groups.

M. Oosterveld, MD, S. Suciu, M.Sc, P. Muus, MD, M. Delforge, MD, A. Belhabri, MD, C. Aul, MD, D. Selleslag, MD, A. Ferrant, MD, J.-P. Marie, MD, S. Amadori, MD, U. Jehn, MD, U. Hess, MD, R. Willemze, MD, E. Hellstrom-Lindberg, MD, M. Vignetti, MD, B. Labar, MD, F. Mandelli, MD, T. De Witte, MD
Journal: Blood
Blood (2004) 104 (11): 2020.
https://doi.org/10.1182/blood.V104.11.2020.2020
Published: 2004